Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

ByFeliza Mirasol,Patrick Lavery

November 19th 2025

Concept image of the six most common questions | Image Credit: © RTimages - stock.adobe.com

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

ByChristopher Cole

November 19th 2025

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

New Targets for Clinical Trials in the European Union

ByCheryl Barton

November 18th 2025

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

ByFeliza Mirasol

November 17th 2025

Cropped shot of doctor holding transparent glass medical vial in hand, focus on bottle | Image Credit: ©MYDAYcontent - stock.adobe.com

Using A Streamlined Workflow to Identify Particulates in Biologic Drugs

BySusan Haigney

November 11th 2025

The Push for Generics Challenges Manufacturers

Articles in this issue

Newsletter

Related Content

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

New Targets for Clinical Trials in the European Union

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

Using A Streamlined Workflow to Identify Particulates in Biologic Drugs

Trending on Pharmaceutical Technology

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

New Targets for Clinical Trials in the European Union

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care